Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Beaumont Hospital treats first patients with whole-body cancer treatment system

Elekta : 30 October, 2007  (New Product)
Beaumont Hospital of Royal Oak, Michigan, USA, has performed its the first treatment using the new Elekta Axesse whole-body cancer treatment system.
Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumour targeting accuracy. The new robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumour targeting

Since 2006, Beaumont Hospital has been running a successful intracranial Radiosurgery programme with Leksell Gamma Knife, and the hospital now is expanding its stereotactic treatment offerings to all parts of the anatomy.

“We chose Elekta Axesse because of its versatility,” said Alvaro Martinez, MD, FACR, corporate chairman, Radiation Oncology, Beaumont Hospitals. “We now can stereotactically treat both intra- and extra-cranial lesions, and the 6D robotically-controlled tabletop gives us the freedom to position the patient at virtually any angle. This enables a much more accurate and precise treatment for these lesions than we could provide in the past.”

Integrating advanced technology and software to elevate the patient experience, streamline clinician workflow

The advanced 3D imaging capabilities of Elekta Axesse facilitate rapid, precise targeting of tumours, and the highly-conformal radiation delivery system effectively treats tumours while minimising damage to patients’ healthy tissue.

“Elekta Axesse enables us to attain sub-millimetre accuracy by planning in 3D and imaging patients in 3D prior to treatment, every day,” said Dr Martinez.

Elekta Axesse also integrates non-invasive patient immobilisation to ensure patients properly are positioned prior to treatment. Working together, these advanced technologies can mean fewer trips to the hospital for patients and less physical, mental and emotional strain.

In addition, by marrying advanced technology with sophisticated software -including one unified display monitor with treatment planning, electronic Medical record (EMR) technology, and system controls - Elekta Axesse smoothes the radiation therapist’s workflow so patients are often finished with their treatments more quickly.

The first patient treated on September 10 with Elekta Axesse underwent radiation therapy for breast cancer. “The patient required extremely precise and accurate treatment twice per day for one week,” said Dr Martinez. “That’s a significantly shorter time period than the traditional seven weeks for this type of case.”

The Elekta Axesse at Beaumont is now in routine clinical use for lung and spinal radiosurgery, as well as for other clinical sites requiring high accuracy and precision. “We have treated a patient who has recurrent cancer around the spinal cord,” said Dr Martinez.

“Elekta Axesse is the only possible treatment option remaining for the patient to prevent damage to the spinal cord that could leave the patient paralysed.”

A third patient has metastases in the adrenal gland. Elekta Axesse can treat the adrenal gland without harming the kidney, small bowel or spinal cord.”

Elekta Axesse also is designed for treatment of prostate cancer.

“We now have robotic control to target the radiation more accurately to the prostate,” said Dr Martinez.

Elekta Axesse has performed well thus far in all treatments, he adds, with an accuracy of within one millimetre.

The innovative new Elekta Axesse provides the world’s most complete portfolio of stereotactic, image-guided treatment solutions with a powerful combination of accuracy, flexibility and dose control. Dr Frank Vicini, MD, chief of Oncology, Beaumont Cancer Institute, Beaumont Hospitals, said the three-dimensional kV volumetric imaging greatly improves the accuracy of tumour targeting. “Elekta Axesse is highly accurate because the real-time imager enables us to adjust, at the time of treatment, the shape and intensity of the radiation delivered.”

Flexibility is vital to any successful radiation treatment, said Dr Vicini. Elekta Axesse allows for multiple energy options and beam shaping options for efficient dose delivery and optimal target conformality, so healthy tissue is spared.

“Quite simply, Elekta Axesse offers better cancer control and fewer side effects,” Dr Vicini said.

Beaumont Hospital, Royal Oak physicians have a nearly 20-year history of partnering with the Elekta R&D team. The hospital has made vital contributions to the development of pioneering 3D imaging and treatment technology.

“We have done research together that has contributed to the development of Elekta Synergy and Elekta Axesse, and we continue to be strong partners in advancing treatment for patients,” Dr Martinez said.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo